Skip to main content
Contact Us
Subscribe
E-Edition
71°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Casi Pharmaceuticals Inc
(NQ:
CASI
)
2.795
+0.115 (+4.29%)
Streaming Delayed Price
Updated: 3:58 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Casi Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
CASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
March 28, 2024
CASI stock results show that CASI Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Recap: CASI Pharmaceuticals Q4 Earnings
March 28, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 07, 2024
Via
Benzinga
CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients
March 05, 2024
CASI Pharmaceuticals and BioInvent share promising results for BI-1206 in treating relapsed/refractory indolent Non-Hodgkin's Lymphoma patients in China. Preliminary data reveals clinical efficacy with...
Via
Benzinga
CASI Pharmaceuticals: Q1 Earnings Insights
May 17, 2023
Via
Benzinga
CASI Pharmaceuticals Earnings Perspective: Return On Capital Employed
May 01, 2023
Via
Benzinga
CASI Pharmaceuticals's Return On Capital Employed Insights
December 26, 2022
Via
Benzinga
Recap: CASI Pharmaceuticals Q2 Earnings
August 12, 2022
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 05, 2024
Via
Benzinga
Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders
February 17, 2024
LianBio, a Princeton-Shanghai biotech, has decided to call it quits. LianBio plans to stop all of its operations by the end of 2024, and it will distribute a $4.80 dividend/share ($528 million) to its...
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
January 25, 2024
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for CASI Pharmaceuticals: Here's What You Need To Know
November 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 03, 2023
Via
Benzinga
Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
October 11, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 11, 2023
Pre-market stock movers are a hot topic on Wednesday morning and we're covering all of the latest news investors need to know about!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 27, 2023
Via
Benzinga
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations
August 05, 2023
Mundipharma is considering selling its China operations in a deal that could be worth $1 billion. Additionally, Oramed Pharma plans to form a $60 million JV with Hefei Tianhui Biotech to commercialize...
Via
Talk Markets
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
July 22, 2023
Novartis signed a $1 billion agreement to acquire DTx Pharma, a preclinical San-Diego company developing siRNA therapies for neuroscience indications. Meanwhile, Zhuhai Biotheus formed a far-reaching...
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
April 10, 2023
Via
Benzinga
Week In Review: Sino Biopharma Subsidiary Enters $307 Million Agreement For Rights To NASH Candidate
September 24, 2022
Chia Tai-Tianqing Pharma, a subsidiary of Sino Biopharma, in-licensed Greater China rights to a therapy for non-alcoholic steatohepatitis from Inventiva in a $307 million deal. Meanwhile, CASI Pharma...
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
September 23, 2022
Gainers
Via
Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
September 26, 2022
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Via
Benzinga
Week In Review: Beijing BoomRay Closes $43 Million A Round For Novel Radionuclide Drugs
September 10, 2022
Beijing BoomRay Pharma, a joint venture between WuXi AppTec and Peking University, completed a $43 million Series A funding to develop novel radionuclide drugs that integrate diagnosis and treatment.
Via
Talk Markets
$2.2 Million Bet On Terns Pharmaceuticals? Check Out These 4 Penny Stocks Insiders Are Buying
September 09, 2022
The Dow Jones closed higher by around 193 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
CASI Pharmaceuticals Earnings Perspective: Return On Capital Employed
September 09, 2022
According to data from Benzinga Pro, during Q2, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $8.57 million. Despite a 10.8% increase in earnings, the company posted a loss of $7.49...
Via
Benzinga
CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying
August 29, 2022
The Dow Jones tumbled by over 1,000 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 16, 2022
Via
Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
August 17, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Via
Benzinga
Earnings Scheduled For August 12, 2022
August 12, 2022
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.